A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Azienda Ospedaliero-Universitaria di Parma
Numab Therapeutics AG
NuCana plc
Medicenna Therapeutics, Inc.
Checkpoint Therapeutics, Inc.
BerGenBio ASA
Aminex Therapeutics, Inc.
Seagen Inc.
Jules Bordet Institute
Quadriga Biosciences, Inc.
Memorial Sloan Kettering Cancer Center
Abramson Cancer Center at Penn Medicine
Swiss Cancer Institute
National Institutes of Health Clinical Center (CC)
GOG Foundation
INSYS Therapeutics Inc
National Institutes of Health Clinical Center (CC)